Evolution of the Average Target: IBM

Evolution of the Average Target - IBM

Evolution of the Target Price: IBM

Evolution of the Target Price - IBM

Changes in Analyst Recommendations: IBM

82ac7b431382511.rjsKUI0NHONk_QOdqgPVJxy39gmpoVGdzTulFiKHJxM.nXdVKvl1Q6k7pFvCmEWtS1PfvmbL6xqtrledJxbebSvNckw513lbkiyvbA~04a41d8233d127503ea81f37a025f565
10-15 Quantum Computing Market Could Grow to $100 Billion-Plus Per Year by 2040, Morgan Stanley Says MT
10-15 Analyst recommendations: Crocs, IBM, Microsoft, Morgan Stanley, Rollins… Zonebourse
10-13 IBM Poised to Deliver 'Solid' Q3 Results, Consistent Free Cash Flow, RBC Says MT
08-31 Susquehanna Adjusts Price Target on IBM to $235 From $225, Keeps Neutral Rating MT
07-29 Daiwa Securities Adjusts Price Target on IBM to $217 From $247, Maintains Neutral Rating MT
07-29 Citic Securities Adjusts Price Target on IBM to $297 From $294, Maintains Buy Rating MT
07-27 HSBC reiterates 'reduce' on IBM Zonebourse
07-24 Susquehanna Adjusts IBM Price Target to $225 From $303, Maintains Neutral Rating MT
07-24 HSBC Adjusts Price Target on IBM to $174 From $175, Maintains Reduce Rating MT
07-23 IBM's 2026 Revenue, Free Cash Flow Guidance Ahead of Expectations, RBC Capital Markets Says MT
07-23 IBM H2 Recovery Plausible on Early Deal Recapture, Higher Productivity, Morgan Stanley Says MT
07-23 Bernstein Adjusts Price Target on IBM to $230 From $280, Maintains Market Perform Rating MT
07-23 Citigroup Cuts Price Target on IBM to $245 From $255, Maintains Buy Rating MT
07-23 Morgan Stanley Adjusts Price Target on IBM to $190 From $293, Maintains Equalweight Rating MT
07-23 Barclays Adjusts Price Target on IBM to $262 From $288, Maintains Overweight Rating MT
07-23 BMO Capital Adjusts Price Target on IBM to $230 From $270, Maintains Market Perform, Rating MT
07-23 Goldman Sachs Adjusts Price Target on IBM to $270 From $335, Maintains Buy Rating MT
07-22 Alphabet Takes the Hot Seat Zonebourse
07-22 Baird Initiates IBM at Neutral With $230 Price Target MT
07-22 Tech set to drive markets forward again Zonebourse
07-21 IBM's Guidance to Get Investor Scrutiny in Q2 Report, RBC Capital Markets Says MT
07-21 RBC Cuts Price Target on IBM to $270 From $300, Keeps Outperform Rating MT
07-21 Jefferies Adjusts Price Target on IBM to $260 From $320, Maintains Buy Rating MT
07-21 Barclays Adjusts Price Target on IBM to $288 From $350, Maintains Overweight Rating MT
07-21 IBM : Jefferies keeps its Buy rating ZD

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+6.48%
+21.07%
+4.04%
+26.88%
+5.89%
+3.7%
+22.49%
+13.2%
+8.45%
+21.01%
Average +13.32%
Weighted average by Cap. +12.78%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
234.12USD
Average target price
242.65USD
Spread / Average Target
+3.64%
High Price Target
297.00USD
Spread / Highest target
+26.86%
Low Price Target
174.00USD
Spread / Lowest Target
-25.68%

Analyst Consensus Detail

Analyst consensus - IBM

Consensus revision (last 18 months)

Consensus revision (last 18 months) - IBM
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - IBM